Clinical implications of conventional cytogenetics, fuorescence in situ hybridization (FISH) and molecular testing in chronic myeloid leukaemia patients in the tyrosine kinase inhibitor era - A review
Despite the excellent treatment results obtained after the introduction of LKI drugs, especially Imatinib mesylate (IM), resistance to LKIs develops in approximately 35% - 40% of CML patients on LKI therapy. Since point mutations in BCR-ABL1 are a common cause of IM resistance, mutation analysis is...
Gespeichert in:
Veröffentlicht in: | Malaysian journal of pathology 2020-12, Vol.42 (3), p.307-321 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!